Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

2.

Effect of combination therapy on joint destruction in rheumatoid arthritis: a network meta-analysis of randomized controlled trials.

Graudal N, Hubeck-Graudal T, Tarp S, Christensen R, Jürgens G.

PLoS One. 2014 Sep 22;9(9):e106408. doi: 10.1371/journal.pone.0106408. eCollection 2014. Review.

3.
4.

Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis: A network meta-analysis.

Hazlewood GS, Barnabe C, Tomlinson G, Marshall D, Devoe DJ, Bombardier C.

Cochrane Database Syst Rev. 2016 Aug 29;(8):CD010227. doi: 10.1002/14651858.CD010227.pub2. Review.

PMID:
27571502
5.

Efficacy of conventional synthetic disease-modifying antirheumatic drugs, glucocorticoids and tofacitinib: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis.

Gaujoux-Viala C, Nam J, Ramiro S, Landewé R, Buch MH, Smolen JS, Gossec L.

Ann Rheum Dis. 2014 Mar;73(3):510-5. doi: 10.1136/annrheumdis-2013-204588. Epub 2014 Jan 6. Review.

6.

Summary of AHRQ's comparative effectiveness review of drug therapy for rheumatoid arthritis (RA) in adults--an update.

Singh JA, Cameron DR.

J Manag Care Pharm. 2012 May;18(4 Supp C):S1-18. Review.

PMID:
22656072
7.

Etanercept for the treatment of rheumatoid arthritis.

Lethaby A, Lopez-Olivo MA, Maxwell L, Burls A, Tugwell P, Wells GA.

Cochrane Database Syst Rev. 2013 May 31;(5):CD004525. doi: 10.1002/14651858.CD004525.pub2. Review.

PMID:
23728649
8.

Effects of glucocorticoids on radiological progression in rheumatoid arthritis.

Kirwan JR, Bijlsma JW, Boers M, Shea BJ.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD006356. Review.

PMID:
17253590
9.

A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.

Chen YF, Jobanputra P, Barton P, Jowett S, Bryan S, Clark W, Fry-Smith A, Burls A.

Health Technol Assess. 2006 Nov;10(42):iii-iv, xi-xiii, 1-229. Review.

10.

Methotrexate monotherapy versus methotrexate combination therapy with non-biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis.

Katchamart W, Trudeau J, Phumethum V, Bombardier C.

Cochrane Database Syst Rev. 2010 Apr 14;(4):CD008495. doi: 10.1002/14651858.CD008495. Review.

PMID:
20393970
11.
12.

A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal.

Choy EH, Smith C, Doré CJ, Scott DL.

Rheumatology (Oxford). 2005 Nov;44(11):1414-21. Epub 2005 Jul 19. Review.

PMID:
16030080
13.

A systematic comparison of combination DMARD therapy and tumour necrosis inhibitor therapy with methotrexate in patients with early rheumatoid arthritis.

Ma MH, Kingsley GH, Scott DL.

Rheumatology (Oxford). 2010 Jan;49(1):91-8. doi: 10.1093/rheumatology/kep331. Epub 2009 Nov 16. Review.

PMID:
19917618
14.

[Effect of disease modifying anti-rheumatic drugs on radiographic progression in rheumatoid arthritis].

Yukawa N, Mimori T.

Clin Calcium. 2009 Mar;19(3):395-403. doi: CliCa0903395403. Review. Japanese.

PMID:
19252250
15.

Drug therapy in undifferentiated arthritis: a systematic literature review.

Wevers-de Boer KV, Heimans L, Huizinga TW, Allaart CF.

Ann Rheum Dis. 2013 Sep 1;72(9):1436-44. doi: 10.1136/annrheumdis-2012-203165. Epub 2013 Jun 6. Review.

PMID:
23744979
16.

Impact of biologic therapy on functional status in patients with rheumatoid arthritis--a meta-analysis.

Callhoff J, Weiß A, Zink A, Listing J.

Rheumatology (Oxford). 2013 Dec;52(12):2127-35. doi: 10.1093/rheumatology/ket266. Epub 2013 Aug 14. Review.

PMID:
23946435
17.
18.

Have traditional DMARDs had their day? Effectiveness of parenteral gold compared to biologic agents.

Rau R.

Clin Rheumatol. 2005 Jun;24(3):189-202. Epub 2004 Jul 24. Review.

PMID:
15940552
19.

The use of conventional disease-modifying anti-rheumatic drugs in established RA.

Jurgens MS, Jacobs JW, Bijlsma JW.

Best Pract Res Clin Rheumatol. 2011 Aug;25(4):523-33. doi: 10.1016/j.berh.2011.10.006. Review.

PMID:
22137922
20.

Abatacept with methotrexate versus other biologic agents in treatment of patients with active rheumatoid arthritis despite methotrexate: a network meta-analysis.

Guyot P, Taylor P, Christensen R, Pericleous L, Poncet C, Lebmeier M, Drost P, Bergman G.

Arthritis Res Ther. 2011;13(6):R204. doi: 10.1186/ar3537. Epub 2011 Dec 12. Review.

Supplemental Content

Support Center